These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30033406)

  • 1. Microbiological quality control of some non-sterile preparations commonly used in Pakistan.
    Rauf A; Erum A; Noreen S; Shujaat J; Ashraf MU; Afreen S
    Pak J Pharm Sci; 2018 Jul; 31(4):1237-1242. PubMed ID: 30033406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unorthodox ophthalmic preparations on the Ghanaian market: a potential risk for ocular and enteric infections.
    Kyei S; Dogbadze E; Tagoh S; Mwanza E
    Afr Health Sci; 2020 Mar; 20(1):515-523. PubMed ID: 33402940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality Control: microbial limit tests for nonsterile pharmaceuticals, part 2.
    Vu N; Lou JR; Kupiec TC
    Int J Pharm Compd; 2014; 18(4):305-10. PubMed ID: 25474859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial contamination of pharmaceutical products in the home.
    Baird RM; Crowden CA; O'Farrell SM; Shooter RA
    J Hyg (Lond); 1979 Oct; 83(2):277-83. PubMed ID: 385768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial contamination in herbal medicines: a serious health hazard to elderly consumers.
    de Sousa Lima CM; Fujishima MAT; de Paula Lima B; Mastroianni PC; de Sousa FFO; da Silva JO
    BMC Complement Med Ther; 2020 Jan; 20(1):17. PubMed ID: 32020854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine triphosphate bioluminescence analysis for rapid screening of microbial contamination in non-sterile pharmaceutical samples.
    Jimenez L
    PDA J Pharm Sci Technol; 2004; 58(3):159-68. PubMed ID: 15233255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial safety implications of in-use topical diagnostic ophthalmic medications in eye clinics in Ghana.
    Kyei S; Appiah E; Ayerakwa EA; Antwi CB; Asiedu K
    J Optom; 2019; 12(4):263-271. PubMed ID: 31473175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microorganisms in drugs and cosmetics - occurrence, harms and consequences in hygienic manufacturing (author's transl)].
    Grigo J
    Zentralbl Bakteriol Orig B; 1976 Jul; 162(3-4):233-87. PubMed ID: 983538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different incubation conditions for microbiological environmental monitoring.
    Gordon O; Berchtold M; Staerk A; Roesti D
    PDA J Pharm Sci Technol; 2014; 68(5):394-406. PubMed ID: 25336415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Milliflex
    Gordon O; Goverde M; Staerk A; Roesti D
    PDA J Pharm Sci Technol; 2017; 71(3):206-224. PubMed ID: 28196917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moulds, yeasts and aerobic plate counts in ginseng supplements.
    Tournas VH; Katsoudas E; Miracco EJ
    Int J Food Microbiol; 2006 Apr; 108(2):178-81. PubMed ID: 16434118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of microbiological quality of pharmaceutical raw materials.
    Bomblies L; Weiss C; Beckmann G
    Pharmeur Sci Notes; 2007 Sep; 2007(1):1-7. PubMed ID: 17993088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Microbial Risk Assessment of Pharmaceutical Products.
    Eissa ME
    PDA J Pharm Sci Technol; 2017; 71(3):245-251. PubMed ID: 27974628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations].
    Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P
    Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial limits reviewed: the basis for unique Australian regulatory requirements for microbial quality of non-sterile pharmaceuticals.
    Tang S
    PDA J Pharm Sci Technol; 1998; 52(3):100-9. PubMed ID: 9691672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection breadth and limits for potential adventitious/endogenous contaminants in biopharmaceutical processes: a reality check for innovative methods.
    Duncan P; McKerral L; Feng S; Tsai PK
    Dev Biol (Basel); 2006; 126():283-90; discussion 327. PubMed ID: 17058504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microbiological quality of muesli samples purchased in retail network].
    Wójcik-Stopczyńska B
    Rocz Panstw Zakl Hig; 2003; 54(3):269-74. PubMed ID: 14755854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiological Quality of Selected Local and Imported Non-Sterile Pharmaceutical Products in Dar es Salaam, Tanzania.
    Myemba DT; Bwire GM; Sangeda RZ
    Infect Drug Resist; 2022; 15():2021-2034. PubMed ID: 35480052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial contamination and preservative efficacy of topical creams.
    Na'was T; Alkofahi A
    J Clin Pharm Ther; 1994 Feb; 19(1):41-6. PubMed ID: 8188790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiological testing of pharmaceuticals and cosmetics in Egypt.
    Zeitoun H; Kassem M; Raafat D; AbouShlieb H; Fanaki N
    BMC Microbiol; 2015 Dec; 15():275. PubMed ID: 26653032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.